Molecular Immunology and Inflammation Branch
Chief, Molecular Immunology and Inflammation Branch
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
National Institutes of Health (NIH)
- Mailing Address :
-
Building 10, Room 9N228
10 Center Drive, MSC 1820
Bethesda, Maryland 20892-1820
Phone: (301)496-6026
Fax: (301)402-0012
The MIIB conducts basic and clinical investigations on the molecular mechanisms underlying immune and inflammatory responses in rheumatic and autoimmune diseases. A major focus of the Branch is the study of receptor-mediated signal transduction and how these events link to the regulation of genes involved in inflammatory responses. The Branch comprises two sections:
Lymphocyte Cell Biology Section - Chief, John J. O'Shea
Conducts research into the molecular basis of cytokine action to define the mechanisms by which these mediators regulate processes such as development, differentiation, memory, tolerance and homeostasis in immune cells. The section also studies patients with primary immunodeficiency and autoinflammatory syndromes.
Molecular Inflammation Section - Chief, Juan Rivera
Conducts research on the molecular mechanisms of the inflammatory response and how immune receptors contribute to inflammation and disease. The section seeks new targets and strategies to control inflammatory rheumatic diseases.
For more detailed information on these two sections, please visit the following web pages:
Lymphocyte Cell Biology Section - Chief, John J. O'Shea
Conducts research into the molecular basis of cytokine action to define the mechanisms by which these mediators regulate processes such as development, differentiation, memory, tolerance and homeostasis in immune cells. The section also studies patients with primary immunodeficiency and autoinflammatory syndromes.
Molecular Inflammation Section - Chief, Juan Rivera
Conducts research on the molecular mechanisms of the inflammatory response and how immune receptors contribute to inflammation and disease. The section seeks new targets and strategies to control inflammatory rheumatic diseases.
For more detailed information on these two sections, please visit the following web pages:
 NIAMS Home |
| About NIAMS IRP | IRP News | Labs & Branches | Jobs & Training |
|
 NIH |
 DHHS |